0001567619-20-004475.txt : 20200220
0001567619-20-004475.hdr.sgml : 20200220
20200220165458
ACCESSION NUMBER: 0001567619-20-004475
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200218
FILED AS OF DATE: 20200220
DATE AS OF CHANGE: 20200220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Campbell James H
CENTRAL INDEX KEY: 0001757390
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 20635990
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2020-02-18
0
0000722723
HANGER, INC.
HNGR
0001757390
Campbell James H
10910 DOMAIN DRIVE, SUITE 300
AUSTIN
TX
78758
0
1
0
0
SVP, Chief Clinical Officer
Common Stock
2020-02-18
4
A
0
4405
0
A
24557
D
Stock Options (right to buy)
12.77
2027-05-19
Common Stock
27328
27328
D
Performance Share Units
2020-05-19
Common Stock
10931
10931
D
Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2019 and ending on December 31, 2019. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date.
Consists of (i) unvested restricted shares totaling 4,405 shares of stock from an initial grant of 4,405 shares of restricted stock that begins to vest on March 8, 2020; (ii) unvested restricted shares totaling 5,220 shares of stock from an initial grant of 5,220 shares of restricted stock that begins to vest on March 8, 2020; (iii) unvested restricted shares and fully vested shares totaling 6,268 shares of stock from an initial grant of 6,710 shares of restricted stock made on March 9, 2018; (iv) unvested restricted shares and fully vested shares totaling 4,820 shares of stock from an initial grant of 7,029 shares of restricted stock made on March 8, 2017; [continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 1,316 shares of stock from an initial grant of 3,000 shares of restricted stock made on October 11, 2016; and (vi) unvested restricted shares and fully vested shares totaling 2,528 shares of stock from an initial grant of 6,008 shares of restricted stock made on April 29, 2016.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Performance Share Units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for James H. Campbell
2020-02-20